← FDA Drug Approvals (Drugs@FDA)

NYSTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: VISTAPHARM LLC · Approved 1998-06-25

Drug application

FDA Application #

ANDA064142

Application type

Abbreviated New Drug Application (Generic)

Brand name

NYSTATIN

Generic name

Nystatin

Active ingredients

NYSTATIN

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Discontinued

Sponsor

VISTAPHARM LLC

First approval

1998-06-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown